Bugworks Research Inc secures $18 million Series B1 funding from Syndicate
This funding will advance highly differentiated assets in the dual areas of antimicrobial resistance (AMR) and Immuno-Oncology…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.